AVXL - ANAVEX LIFE SCIENCES CORPORATION (NASDAQ: AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline | Benzinga
NEW YORK, April 22, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:
- Do you, or did you, own shares of Anavex Life Sciences Corporation (NASDAQ:AVXL)?
- Did you purchase your shares between February 1, 2022 and January 1, 2024, inclusive?
- Did you lose money in your investment in Anavex Life Sciences Corporation?
- Do you want to discuss your rights?
Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the stock of Anavex Life Sciences Corporation ("Anavex" or the "Company") (NASDAQ:AVXL) between February 1, 2022 and January 1, 2024, inclusive (the "Class Period"). The lawsuit was filed in the United States District Court for the Southern District of New York and alleges violations of the Securities Exchange Act of 1934 against the Company and certain of its officers (the "Complaint").
If you purchased or acquired Anavex stock, and/or would like to discuss your legal rights and options please visit Anavex Life Sciences Corporation Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or pallocco@bernlieb.com.
If you wish to serve as lead plaintiff, you must move the Court no ...
AVXL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Anavex Life Sciences Corporation Investors of Upcoming Deadline>Full story available on Benzinga.com